Cooperation With Sinopharm Marks Turning Point For Merro Pharma
This article was originally published in PharmAsia News
Executive Summary
With the transfer of two subsidiaries worth a total of RMB 33.96 million, and cooperation with Sinopharm about to begin, Merro Pharmaceutical's latest moves mark a positive turning point in performance